Filing Details
- Accession Number:
- 0001140361-18-044399
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-03 16:01:29
- Reporting Period:
- 2018-11-21
- Accepted Time:
- 2018-12-03 16:01:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1398733 | Aquestive Therapeutics Inc. | AQST | Pharmaceutical Preparations (2834) | 208623253 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740092 | W. Ken Marshall | C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059 | Commercial Leader | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-21 | 1,445 | $10.15 | 1,445 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Footnotes
- Shares held by the Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall.
Billionaire Hedge Funds
